Klaus Strein founded EngMab SARL. Currently, Dr. Strein is Chairman for Lamkap Bio AG and Chairman at EngMab SARL.
He is also on the board of BB Biotech AG and Novimmune SA.
In the past he was Head-Small Molecules Research at Roche Holding AG.
Dr. Strein received a doctorate from Ruprecht-Karls-Universität Heidelberg.